Elevance Health Inc. (ELV) Tops Q2 EPS by 124c, raises guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts ELV Hot Sheet
Join SI Premium – FREE
Elevance Health Inc. (NYSE: ELV) reported Q2 EPS of $7.45, $1.24 better than the analyst estimate of $6.21. Revenue for the quarter came in at $49.8 billion versus the consensus estimate of $48.63 billion.
GUIDANCE:
Elevance Health Inc. sees FY2026 EPS of at least $27.00, versus the consensus of $26.91.
For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Calix, Inc. (CALX) Tops Q3 EPS by 3c; offers guidance
- EverQuote (EVER) Tops Q3 EPS by 2c; Offers Guidance
- People Incorporated (PPLI) Misses Q3 EPS by 896c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
